These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 18343809)

  • 1. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.
    Sinisi AA; Esposito D; Maione L; Quinto MC; Visconti D; De Bellis A; Bellastella A; Conzo G; Bellastella G
    Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
    Rohayem J; Hauffa BP; Zacharin M; Kliesch S; Zitzmann M;
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism.
    Cisternino M; Manzoni SM; Coslovich E; Autelli M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():885-90. PubMed ID: 10091162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism.
    Young J; Chanson P; Salenave S; Noël M; Brailly S; O'Flaherty M; Schaison G; Rey R
    J Clin Endocrinol Metab; 2005 Feb; 90(2):724-8. PubMed ID: 15536161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome.
    Raivio T; Wikström AM; Dunkel L
    Eur J Endocrinol; 2007 Jan; 156(1):105-11. PubMed ID: 17218732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian hormone in seminal plasma and serum: association with sperm count and sperm motility.
    Andersen JM; Herning H; Witczak O; Haugen TB
    Hum Reprod; 2016 Aug; 31(8):1662-7. PubMed ID: 27220981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin.
    Warne DW; Decosterd G; Okada H; Yano Y; Koide N; Howles CM
    Fertil Steril; 2009 Aug; 92(2):594-604. PubMed ID: 18930225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seminal plasma anti-Müllerian hormone level correlates with semen parameters but does not predict success of testicular sperm extraction (TESE).
    Mostafa T; Amer MK; Abdel-Malak G; Nsser TA; Zohdy W; Ashour S; El-Gayar D; Awad HH
    Asian J Androl; 2007 Mar; 9(2):265-70. PubMed ID: 17334594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Müllerian hormone in men with normal and reduced sperm concentration and men with maldescended testes.
    Tüttelmann F; Dykstra N; Themmen AP; Visser JA; Nieschlag E; Simoni M
    Fertil Steril; 2009 May; 91(5):1812-9. PubMed ID: 18423454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis.
    Zacharin M; Sabin MA; Nair VV; Dabadghao P
    Fertil Steril; 2012 Oct; 98(4):836-42. PubMed ID: 22763096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of inhibin B and anti-Müllerian hormone in seminal plasma: a preliminary study.
    Duvilla E; Lejeune H; Trombert-Paviot B; Gentil-Perret A; Tostain J; Levy R
    Fertil Steril; 2008 Feb; 89(2):444-8. PubMed ID: 17681330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
    Ley SB; Leonard JM
    J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
    Muttukrishna S; Suharjono H; McGarrigle H; Sathanandan M
    BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-Müllerian hormone (AMH) measurements in the assessment of testicular function in prepubertal boys and in sexual differentiation disorders].
    Szarras-Czapnik M; Gajewska M; Ksiazyk J; Janas R; Ginalska-Malinowska M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):195-9. PubMed ID: 17020655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults.
    Rohayem J; Sinthofen N; Nieschlag E; Kliesch S; Zitzmann M
    Andrology; 2016 Jan; 4(1):87-94. PubMed ID: 26779870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Combined Low Dose Human Gonadotropic Hormone, Follicle Stimulating Hormone, and Testosterone Therapy (LFT Regimen) Versus Conventional High Dose Human Gonadotropic Hormone and Follicle Stimulating Hormone on Spermatogenesis and Biomarkers in Men With Hypogonadotropic Hypogonadism.
    Singhania N; Devi KB; Kaur J; Bhansali A; Gorsi U; Sachdeva N; Arora S; Rai A; Walia R
    Endocr Pract; 2024 Oct; 30(10):978-986. PubMed ID: 39025301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testis function in prepubertal boys and young men born small for gestational age.
    Boonstra VH; Weber RF; de Jong FH; Hokken-Koelega AC
    Horm Res; 2008; 70(6):357-63. PubMed ID: 18953173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimüllerian hormone in patients with hypogonadotropic hypogonadism.
    Young J; Rey R; Couzinet B; Chanson P; Josso N; Schaison G
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2696-9. PubMed ID: 10443662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans.
    Young J; Rey R; Schaison G; Chanson P
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):51-4. PubMed ID: 14656476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.